Literature DB >> 17651439

Limited suppression of the interferon-beta production by hepatitis C virus serine protease in cultured human hepatocytes.

Hiromichi Dansako1, Masanori Ikeda, Nobuyuki Kato.   

Abstract

Toll-like receptors and RNA helicase family members [retinoic acid-inducible gene I (RIG-I) and melanoma differentiation associated gene-5 (MDA5)] play important roles in the induction of interferon-beta as a major event in innate immune responses after virus infection. TRIF (adaptor protein of Toll-like receptor 3)-mediated and Cardif (adaptor protein of RIG-I or MDA5)-mediated signaling pathways contribute rapid induction of interferon-beta through the activation of interferon regulatory factor-3 (IRF-3). Previously, it has been reported that the hepatitis C virus NS3-4A serine protease blocks virus-induced activation of IRF-3 in the human hepatoma cell line HuH-7, and that NS3-4A cleaves TRIF and Cardif molecules, resulting in the interruption of antiviral signaling pathways. On the other hand, it has recently been reported that non-neoplastic human hepatocyte PH5CH8 cells retain robust TRIF- and Cardif-mediated pathways, unlike HuH-7 cells, which lack a TRIF-mediated pathway. In the present study, we further investigated the effect of NS3-4A on antiviral signaling pathways. Although we confirmed that PH5CH8 cells were much more effective than HuH-7 cells for the induction of interferon-beta, we obtained the unexpected result that NS3-4A could not suppress the interferon-beta production induced by the TRIF-mediated pathway, although it suppressed the Cardif-mediated pathway by cleaving Cardif at the Cys508 residue. Using PH5CH8, HeLa, and HuH-7-derived cells, we further showed that NS3-4A could not cleave TRIF, in disagreement with a previous report describing the cleavage of TRIF by NS3-4A. Taken together, our findings suggest that the blocking of the interferon production by NS3-4A is not sufficient in HCV-infected hepatocyte cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17651439     DOI: 10.1111/j.1742-4658.2007.05942.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  15 in total

1.  Cell cycle progression or translation control is not essential for vesicular stomatitis virus oncolysis of hepatocellular carcinoma.

Authors:  Sabrina Marozin; Enrico N De Toni; Antonia Rizzani; Jennifer Altomonte; Alexandra Junger; Günter Schneider; Wolfgang E Thasler; Nobuyuki Kato; Roland M Schmid; Oliver Ebert
Journal:  PLoS One       Date:  2010-06-07       Impact factor: 3.240

2.  Toll-like receptor 3 mediates establishment of an antiviral state against hepatitis C virus in hepatoma cells.

Authors:  Nan Wang; Yuqiong Liang; Santhana Devaraj; Jie Wang; Stanley M Lemon; Kui Li
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

Review 3.  Intracellular innate immune cascades and interferon defenses that control hepatitis C virus.

Authors:  Stacy M Horner; Michael Gale
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

4.  Hepatitis C and innate immunity: recent advances.

Authors:  Gyongyi Szabo; Angela Dolganiuc
Journal:  Clin Liver Dis       Date:  2008-08       Impact factor: 6.126

5.  Hepacivirus NS3/4A Proteases Interfere with MAVS Signaling in both Their Cognate Animal Hosts and Humans: Implications for Zoonotic Transmission.

Authors:  Richard J P Brown; Dominic H Banda; Daniel Todt; Gabrielle Vieyres; Eike Steinmann; Thomas Pietschmann
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

Review 6.  Innate immune responses in hepatitis C virus infection.

Authors:  Kui Li; Stanley M Lemon
Journal:  Semin Immunopathol       Date:  2012-08-07       Impact factor: 9.623

Review 7.  Interaction of Hepatitis C virus proteins with pattern recognition receptors.

Authors:  Muhammad Imran; Yasir Waheed; Sobia Manzoor; Muhammad Bilal; Waseem Ashraf; Muhammad Ali; Muhammad Ashraf
Journal:  Virol J       Date:  2012-06-22       Impact factor: 4.099

8.  Class A scavenger receptor 1 (MSR1) restricts hepatitis C virus replication by mediating toll-like receptor 3 recognition of viral RNAs produced in neighboring cells.

Authors:  Hiromichi Dansako; Daisuke Yamane; Christoph Welsch; David R McGivern; Fengyu Hu; Nobuyuki Kato; Stanley M Lemon
Journal:  PLoS Pathog       Date:  2013-05-23       Impact factor: 6.823

9.  Cleavage of the IPS-1/Cardif/MAVS/VISA does not inhibit T cell-mediated elimination of hepatitis C virus non-structural 3/4A-expressing hepatocytes.

Authors:  G Ahlén; E Derk; M Weiland; J Jiao; N Rahbin; S Aleman; D L Peterson; K Pokrovskaja; D Grandér; L Frelin; M Sällberg
Journal:  Gut       Date:  2008-08-08       Impact factor: 23.059

10.  The DNA damage sensors ataxia-telangiectasia mutated kinase and checkpoint kinase 2 are required for hepatitis C virus RNA replication.

Authors:  Yasuo Ariumi; Misao Kuroki; Hiromichi Dansako; Ken-Ichi Abe; Masanori Ikeda; Takaji Wakita; Nobuyuki Kato
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.